(147) TOPICAL ADMINISTRATION OF MED3000 GEL SIGNIFICANTLY IMPROVES SELF-ESTEEM AND RELATIONSHIPS IN MEN WITH ERECTILE DYSFUNCTION: RESULTS FROM TWO CLINICAL TRIALS
Notice bibliographique
Résumé
Abstract Introduction Erectile dysfunction (ED) negatively impacts self-esteem, confidence, relationships, and quality of life while effective treatment of ED improves these measures. MED3000 is a FDA-cleared, topical treatment for ED that has been shown to be effective for the treatment ED, but effects on psychosocial outcomes have not been reported. Objective To assess the effects of MED3000 in men with ED using the Self-esteem and Relationship (SEAR) questionnaire. Methods Two multicenter studies were performed (n = 298 total). Both studies enrolled patients with a clinical diagnosis of ED for >3 months based the National Institutes of Health Consensus Statement. The first (Study 1) had a duration of 12 weeks and the second (Study 2) was 24 weeks. Subjects or their female partners were instructed to apply MED3000 immediately prior to sexual intercourse and subjects were instructed to make at least 4 intercourse attempts in each of the three or six 4-week periods during treatment. Subjects completed the 14-item SEAR questionnaire every 4 weeks for the duration of the study periods. Results for individual scores were combined and transformed into domain and total scores (1-100, higher scores indicate more favorable responses). Results for non-missing data for each 4-week period were combined to provide a mean change from baseline over 12 (Study 1) or 24 (Study 2) weeks. Significance (P < 0.005 with Bonferroni correction) of mean changes from baseline over 12 or 24 weeks were determined with paired t-tests. Results Study 1 enrolled a total of 250 subjects (mean age □ standard deviation (SD) = 46.8□12.5 years, duration of ED = 27.5□36.5 months, 59.2%, 28.0%, and 12.8% with mild, moderate, or severe ED, respectively). Study 2 enrolled 48 subjects (44 White, 4 Black, 46.1□13.5 years old, duration of ED = 28.9□32.3 months, 39.6%, 35.4%, and 25.0% with mild, moderate, or severe ED). In both studies, MED3000 resulted in statistically significant improvements in total scores and for all individual SEAR domains except Overall Relationship Satisfaction in Study 2 (Table 1). Results from both studies indicated that SEAR total and domain score changes from baseline exceeded the minimal clinically meaningful improvement (>10 points) for this measure. At the end of the trial, 81.2% of men in Study 1 and 85.4% in Study 2 felt that sex could be spontaneous. Table 1. SEAR questionnaire results (mean ± SD) Study 1 (N = 250) Study 2 (N = 48) Baseline Change from Baseline over the 12-week Period P-value Baseline Change from Baseline over the 24-week Period P-value Total Score 38.7 ± 15.9 14.7 ± 18.6 < 0.001 44.6 ± 17.5 12.5 ± 16.8 < 0.001 Sexual Relationship and Satisfaction Domain (MCMI >10-point change) 38.1 ± 17.1 15.6 ± 19.9 < 0.001 41.9 ± 19.6 13.8 ± 17.9 < 0.001 Confidence Domain (MCMI >10-point change) 39.4 ± 15.9 13.6 ± 18.9 < 0.001 48.2 ± 16.1 10.8 ± 16.6 < 0.005 Self-esteem Domain (MCMI >10-point change) 38.2 ± 15.4 11.8 ± 17.4 < 0.001 42.6 ± 14.6 11.1 ± 18.3 < 0.001 Overall Relationship Satisfaction Domain (MCMI not defined) 41.9 ± 23.4 17.1 ± 28.1 < 0.001 59.4 ± 27.2 10.1 ± 24.5 0.009 MICI, minimal clinically meaningful improvement. Conclusions Study results from two multicenter trials showed that MED3000 resulted in statistically significant and clinically meaningful improvements in self-esteem and relationships as reflected by SEAR total and domain scores. These findings provide further support for the benefit of MED3000 in men with ED. Disclosure Yes, this is sponsored by industry/sponsor: Futura Pharmaceuticals/Haleon. Clarification: Industry initiated, executed and funded study. Any of the authors act as a consultant, employee or shareholder of an industry for: Futura and Haleon.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,009 | 0,005 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,001 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».